| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 905.14 KB | Adobe PDF |
Authors
Abstract(s)
Introdução: Desde o seu aparecimento em Portugal, em 2006, que as vacinas utilizadas no combate à infeção pelo Vírus do Papiloma Humano têm despoletado controvérsia sobre a sua aplicabilidade, segurança, eficácia e relação custo-benefício, especialmente devido ao seu tempo de utilização, de cerca de 9 anos. A sua administração em jovens (para já no sexo feminino) foi introduzida no Plano Nacional de Vacinação em 2008. A evidência científica sugere o benefício da vacinação para além das jovens abrangidas pelo Plano Nacional de Vacinação, pelo que se torna importante aumentar a adesão à vacinação. Várias estratégias têm sido utilizadas, nas quais a comunicação com os profissionais de saúde adquire forte relevância para o sucesso da implementação deste tipo de medidas preventivas. Os objetivos deste estudo foram inquirir do grau de implementação, concordância e aconselhamento por parte de médicos na área da Ginecologia e Obstetrícia sobre a utilização da vacinação profilática contra o Vírus do Papiloma Humano.
Metodologia: Durante o 20º Congresso de Obstetrícia e Ginecologia (outubro 2014, Centro de Congressos Altis de Lisboa), foi distribuído um inquérito, por nós elaborado e validado, anónimo e de preenchimento voluntário, dirigido a internos e especialistas da área de Ginecologia e Obstetrícia. O inquérito consistiu de questões para caracterização demográfica, grau de concordância com a vacinação nos diferentes grupos etários e tipo de aconselhamento perante diferentes situações, nomeadamente relacionadas com o género.
Resultados: Dos 206 profissionais que responderam ao inquérito, a maioria era do sexo feminino, especialistas e na faixa etária entre os 25 e os 40 anos. 98,5% referiram concordar com a inclusão da vacina no Plano Nacional de Vacinação, 86,3% aconselham todas as mulheres a serem vacinadas até aos 26 anos, 40,9% igualmente dos 27 aos 45 anos e depois dos 45 anos, apenas, 4,4% aconselham todas as mulheres. 79,1% dos inquiridos responderam que aconselham sempre as suas utentes a vacinarem as filhas (sexo feminino) e 37,4% aconselham as utentes a vacinarem os filhos (sexo masculino). Apenas 17,4% aconselham a vacinação do parceiro sexual da utente.
Conclusão: Os médicos inquiridos demonstram elevada adesão para a vacinação das mulheres até aos 26 anos. Para a vacinação de mulheres com idades superiores aos 26 anos e no sexo masculino, há que desenvolver estratégias de sensibilização à classe médica.
Introduction: Since its appearance in Portugal, in 2006, that the vaccines used in the fight against infection by the Human Papilloma Virus have sparked many debates about its applicability, safety, efficacy and cost-effectiveness, especially due to its time of use, about 9 years. Its administration in young (just females for now) was introduced in the National Vaccination Plan in 2008. The scientific evidence suggests the benefit of vaccination beyond youth covered by the National Vaccination Plan, therefore is important the increase of the adhesion to the vaccination. Several strategies have been used, in which the communication with health professionals get extremely relevant for the successful implementation of such preventive measures. The objectives of this study were to investigate the degree of implementation, agreement and advice from doctors in the area of Obstetrics and Gynecology on the use of prophylactic vaccination against the Human Papilloma Virus. Methodology: During the 20th Congress of Obstetrics and Gynecology (October 2014 Altis Congress Centre, Lisbon), a survey was distributed, by us developed and validated, anonymous and voluntary, aimed at residents and specialists of Gynecology and Obstetrics. The survey consisted of questions for demographic characteristics, degree of agreement with the vaccination in different age groups and type of counseling in different situations, particularly with respect to gender. Results: Of the 206 professionals who responded to the survey, most were women, specialists and aged between 25 and 40 years. 98.5% reported agree with the inclusion of the vaccine in the National Vaccination Plan, 86.3% advise all women to be vaccinated up to 26 years, 40.9% also from 27 to 45 years and after 45 years, only 4.4% advise all women. 79.1% of participants said they always advise their patients to vaccinate their daughters (female) and 37.4% advise patients to vaccinate their children (male). Only 17.4% advise vaccination of the sexual partner of the patient. Conclusion: The physicians surveyed demonstrate high adhesion to vaccination of women up to 26 years. For the vaccination of women over the age of 26 and in men, there is necessity of the development of sensibilization strategies to physicians.
Introduction: Since its appearance in Portugal, in 2006, that the vaccines used in the fight against infection by the Human Papilloma Virus have sparked many debates about its applicability, safety, efficacy and cost-effectiveness, especially due to its time of use, about 9 years. Its administration in young (just females for now) was introduced in the National Vaccination Plan in 2008. The scientific evidence suggests the benefit of vaccination beyond youth covered by the National Vaccination Plan, therefore is important the increase of the adhesion to the vaccination. Several strategies have been used, in which the communication with health professionals get extremely relevant for the successful implementation of such preventive measures. The objectives of this study were to investigate the degree of implementation, agreement and advice from doctors in the area of Obstetrics and Gynecology on the use of prophylactic vaccination against the Human Papilloma Virus. Methodology: During the 20th Congress of Obstetrics and Gynecology (October 2014 Altis Congress Centre, Lisbon), a survey was distributed, by us developed and validated, anonymous and voluntary, aimed at residents and specialists of Gynecology and Obstetrics. The survey consisted of questions for demographic characteristics, degree of agreement with the vaccination in different age groups and type of counseling in different situations, particularly with respect to gender. Results: Of the 206 professionals who responded to the survey, most were women, specialists and aged between 25 and 40 years. 98.5% reported agree with the inclusion of the vaccine in the National Vaccination Plan, 86.3% advise all women to be vaccinated up to 26 years, 40.9% also from 27 to 45 years and after 45 years, only 4.4% advise all women. 79.1% of participants said they always advise their patients to vaccinate their daughters (female) and 37.4% advise patients to vaccinate their children (male). Only 17.4% advise vaccination of the sexual partner of the patient. Conclusion: The physicians surveyed demonstrate high adhesion to vaccination of women up to 26 years. For the vaccination of women over the age of 26 and in men, there is necessity of the development of sensibilization strategies to physicians.
Description
Keywords
Cancro do Colo do Útero Plano Nacional de Vacinação Prevenção Vacinação Vírus do Papiloma Humano